Lemonade, Inc. (LMND) Stock Price & How to Invest

Lemonade is a technology-first insurance company that offers renters, homeowners, car, pet, and life policies across the United States and parts of Europe, using AI and behavioral-economics-based design to automate quoting, underwriting, and claims. Its model is built around a chatbot-driven customer experience, a flat-fee revenue structure, and a giveback that donates unused premiums, which the company uses to differentiate from legacy carriers like State Farm, Allstate, and Progressive.

The investment picture centers on whether Lemonade can convert fast top-line growth into durable profits. In-force premium reached roughly $1.33 billion in Q1 2026, up about 32% year over year, and the gross loss ratio improved to the low 60s percent, but the company still posted a net loss. Investors are weighing accelerating premium growth, expanding car and pet lines, and AI-driven efficiency against catastrophe exposure, reinsurance economics, and a bottom line that has not yet turned positive.

Lemonade remains unprofitable on a net basis, posting a net loss of roughly ($36) million in Q1 2026, so profitability depends on execution that has not yet been proven at scale. Catastrophe exposure, especially in homeowners and property lines, can spike loss ratios in any given quarter. Reinsurance terms materially affect reported revenue and retained risk, adding volatility. The company competes against far larger, better-capitalized incumbents, and the stock has historically been highly volatile, making it a higher-risk holding.

9 analysts publish price targets on LMND, averaging $61.22 against a $48.31 price as of August 2026, or +26.7%. The published targets run from $37.00 to $92.00, a wide spread, and the ratings split 3 buy, 6 hold, 2 sell. Over the last six months there have been 3 raises and 5 cuts among the published actions. A price target is what an analyst published on a date, not a prediction, and sell-side ratings skew positive across the whole market.

Read the full LMND forecast and price target for the target table, the recent rating actions by firm, and how the consensus has shifted.

We give no verdict on Lemonade, Inc.. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.

The case for buying. Accelerating premium growth. In-force premium reached about $1.33 billion in Q1 2026, up roughly 32% year over year, extending a streak of accelerating growth over ten consecutive quarters. The most optimistic published target, $92.00, assumes this works close to its best case.

The case against. Lemonade remains unprofitable on a net basis, posting a net loss of roughly ($36) million in Q1 2026, so profitability depends on execution that has not yet been proven at scale. The most pessimistic target, $37.00, is roughly what LMND is worth if this bites instead.

Read the full bull and bear case on LMND, including what would have to change to break either one. Walnut is not an investment adviser.

A simple financial snapshot. These are approximations and refresh quarterly; for current figures see Lemonade, Inc.'s investor relations page or your broker.

• Revenue (Q1 2026): ~$258M
• Revenue growth (YoY): ~71%
• In-force premium: ~$1.33B
• Customers: ~3.14M
• Net loss (Q1 2026): ~($36M)
• Market cap: ~$6B

Q1 2026 revenue grew about 71% to roughly $258 million, helped by a reinsurance transition and higher premium retention, while gross profit rose sharply. The stock traded near the high-$70s per share in early July 2026 for a market cap around $6 billion. Because Lemonade is still net-loss-making, its valuation reflects expected future growth rather than current earnings.

Other names that sit close to LMND: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. Worth a look if you are thinking about diversification within a thesis rather than concentration on one ticker.

There are three common ways to get LMND exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic portfolio, so LMND sits alongside other stocks that express the same thesis.

Walnut takes the portfolio route. Describe a thesis where LMND fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

LMND pairs rapid premium growth and improving loss ratios with a path toward positive adjusted EBITDA, but it remains unprofitable on a net basis, which keeps it a higher-risk insurtech holding.

Whether LMND is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is LMND a buy or a sell?, and where the stock could go from here in the LMND stock forecast.

For income investors, whether LMND pays a dividend and how the payout looks is covered in does LMND pay a dividend? And to weigh LMND against a peer, read the full side-by-side comparisons: LMND vs SLDE and LMND vs WRB.